Hyewon Youn

4.6k total citations · 2 hit papers
108 papers, 3.6k citations indexed

About

Hyewon Youn is a scholar working on Molecular Biology, Oncology and Biomedical Engineering. According to data from OpenAlex, Hyewon Youn has authored 108 papers receiving a total of 3.6k indexed citations (citations by other indexed papers that have themselves been cited), including 50 papers in Molecular Biology, 21 papers in Oncology and 18 papers in Biomedical Engineering. Recurrent topics in Hyewon Youn's work include Nanoparticle-Based Drug Delivery (12 papers), Nanoplatforms for cancer theranostics (11 papers) and Radiopharmaceutical Chemistry and Applications (10 papers). Hyewon Youn is often cited by papers focused on Nanoparticle-Based Drug Delivery (12 papers), Nanoplatforms for cancer theranostics (11 papers) and Radiopharmaceutical Chemistry and Applications (10 papers). Hyewon Youn collaborates with scholars based in South Korea, United States and Ethiopia. Hyewon Youn's co-authors include Keon Wook Kang, June-Key Chung, Dong Soo Lee, June‐Key Chung, Sun Ha Paek, Kyungho Choi, Yun‐Sang Lee, Kee‐Jong Hong, Yeong‐Jin Choi and Hyo Eun Moon and has published in prestigious journals such as Nature Communications, The Journal of Immunology and PLoS ONE.

In The Last Decade

Hyewon Youn

107 papers receiving 3.5k citations

Hit Papers

A bioprinted human-glioblastoma-on-a-chip for the identif... 2019 2026 2021 2023 2019 2022 100 200 300 400
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. A bioprinted human-glioblastoma-on-a-chip for the identification of patient-specific responses to chemoradiotherapy
    2019 485 citations Hyewon Youn et al. profile →
  2. Lipid nanoparticles for delivery of RNA therapeutics: Current status and the role of in vivo imaging
    2022 152 citations Seok‐Yong Lee, Hyewon Youn et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hyewon Youn South Korea 30 1.6k 1.0k 500 493 466 108 3.6k
Sarah Shigdar Australia 33 2.4k 1.5× 828 0.8× 799 1.6× 449 0.9× 483 1.0× 68 3.6k
Jun Qian China 28 1.9k 1.2× 514 0.5× 448 0.9× 436 0.9× 577 1.2× 113 3.5k
In-San Kim South Korea 36 2.1k 1.3× 886 0.9× 535 1.1× 520 1.1× 967 2.1× 68 3.8k
Guanbin Song China 38 1.9k 1.2× 1.1k 1.1× 681 1.4× 770 1.6× 461 1.0× 144 4.9k
Masamitsu Tanaka Japan 35 2.0k 1.3× 663 0.7× 574 1.1× 431 0.9× 500 1.1× 92 4.4k
Shinae Kizaka‐Kondoh Japan 35 2.3k 1.4× 934 0.9× 784 1.6× 1.3k 2.5× 315 0.7× 110 4.4k
Wanhai Xu China 35 1.8k 1.1× 892 0.9× 519 1.0× 735 1.5× 669 1.4× 139 3.5k
Abhijit De India 37 3.0k 1.9× 1.4k 1.4× 910 1.8× 494 1.0× 678 1.5× 119 5.6k
Maryam Moghaddam Matin Iran 33 2.3k 1.4× 882 0.9× 484 1.0× 567 1.2× 681 1.5× 237 4.5k
Haruhiko Kamada Japan 38 1.6k 1.0× 570 0.6× 413 0.8× 339 0.7× 566 1.2× 140 3.8k

Countries citing papers authored by Hyewon Youn

Since Specialization
Citations

This map shows the geographic impact of Hyewon Youn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hyewon Youn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hyewon Youn more than expected).

Fields of papers citing papers by Hyewon Youn

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hyewon Youn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hyewon Youn. The network helps show where Hyewon Youn may publish in the future.

Co-authorship network of co-authors of Hyewon Youn

This figure shows the co-authorship network connecting the top 25 collaborators of Hyewon Youn. A scholar is included among the top collaborators of Hyewon Youn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hyewon Youn. Hyewon Youn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Park, Pil‐Gu, et al.. (2024). Current development of therapeutic vaccines for the treatment of chronic infectious diseases. Clinical and Experimental Vaccine Research. 13(1). 21–21. 3 indexed citations
2.
Shin, Jun‐Hye, Seok‐Yong Lee, Jongchan Kim, et al.. (2024). Enhanced efficacy of glycoengineered rice cell‐produced trastuzumab. Plant Biotechnology Journal. 22(11). 3068–3081. 2 indexed citations
3.
Kim, Ki Hyun, Ju Hwan Kim, Min Ju Kang, et al.. (2024). Improved safety of chimeric antigen receptor T cells indirectly targeting antigens via switchable adapters. Nature Communications. 15(1). 9917–9917. 9 indexed citations
4.
Kim, Shin‐Il, Seok‐Yong Lee, Keon Wook Kang, et al.. (2023). Activated Natural Killer Cell Inoculation Alleviates Fibrotic Liver Pathology in a Carbon Tetrachloride-Induced Liver Cirrhosis Mouse Model. Biomedicines. 11(4). 1090–1090. 3 indexed citations
5.
Lee, Seok‐Yong, Younghwa Kim, Sung‐Hwan Bae, et al.. (2023). Abstract 5046: Cerenkov luminescence imaging of interscapular brown adipose tissue using TSPO-targeting probe to overcome off-target effect of [18F]FDG. Cancer Research. 83(7_Supplement). 5046–5046. 1 indexed citations
6.
Kong, Seong‐Ho, Felix Berlth, Jae Hwan Shin, et al.. (2021). Evaluation of Near-infrared Fluorescence-conjugated Peptides for Visualization of Human Epidermal Receptor 2-overexpressed Gastric Cancer. Journal of the Korean Gastric Cancer Association. 21(2). 191–191. 6 indexed citations
7.
Berlth, Felix, Ji‐Hyeon Park, Jong‐Ho Choi, et al.. (2021). Glucose metabolic profiles evaluated by PET associated with molecular characteristic landscape of gastric cancer. Gastric Cancer. 25(1). 149–160. 3 indexed citations
8.
Lee, Sang-Woo, Cheol-Min Kim, Hyewon Youn, & Kyungho Choi. (2017). Thyroid hormone disrupting potentials of bisphenol A and its analogues - in vitro comparison study employing rat pituitary (GH3) and thyroid follicular (FRTL-5) cells. Toxicology in Vitro. 40. 297–304. 68 indexed citations
9.
Kang, Se Hun, Young-Hwa Kim, Kyeong Sik Jin, et al.. (2017). Toward redesigning the PEG surface of nanocarriers for tumor targeting: impact of inner functionalities on size, charge, multivalent binding, and biodistribution. Chemical Science. 8(7). 5186–5195. 6 indexed citations
10.
Bakht, Martin, So Won Oh, Hyewon Youn, et al.. (2016). Influence of Androgen Deprivation Therapy on the Uptake of PSMA-Targeted Agents: Emerging Opportunities and Challenges. Nuclear Medicine and Molecular Imaging. 51(3). 202–211. 51 indexed citations
11.
12.
13.
Youn, Hyewon, et al.. (2015). Subdominant H60 antigen-specific CD8 T-cell response precedes dominant H4 antigen-specific response during the initial phase of allogenic skin graft rejection. Experimental & Molecular Medicine. 47(2). e140–e140. 6 indexed citations
14.
Lee, Seulki, Juri Na, Ji‐Hye Park, et al.. (2014). Targeting BRG1 Chromatin Remodeler via Its Bromodomain for Enhanced Tumor Cell Radiosensitivity In Vitro and In Vivo. Molecular Cancer Therapeutics. 14(2). 597–607. 27 indexed citations
15.
Hwang, Do Won, Kyung Min Park, Hye‐kyung Shim, et al.. (2014). In vivo bioluminescence imaging for viable human neural stem cells incorporated within in situ gelatin hydrogels. EJNMMI Research. 4(1). 61–61. 3 indexed citations
16.
Yao, Kai, Hyewon Youn, Xiaoyan Gao, et al.. (2012). Casein kinase 2 inhibition attenuates androgen receptor function and cell proliferation in prostate cancer cells. The Prostate. 72(13). 1423–1430. 23 indexed citations
17.
Jeong, Jae Min, Yun‐Sang Lee, Hyewon Youn, et al.. (2011). Facile preparation of multimodal QDs using specially designed amphiphiles for targeting angiogenesis. 52(6). 295–295. 2 indexed citations
18.
Hwang, Do Won, Hyewon Youn, & Dong Soo Lee. (2010). Molecular Imaging Using PET/MRI Particle. 2(1). 186–191. 5 indexed citations
19.
Sun, Andy, et al.. (2006). Conditional Akt activation promotes androgen-independent progression of prostate cancer. Carcinogenesis. 28(3). 572–583. 44 indexed citations
20.
Nalbant, Demet, Hyewon Youn, Selim Nalbant, et al.. (2005). FAM20: an evolutionarily conserved family of secreted proteins expressed in hematopoietic cells. BMC Genomics. 6(1). 11–11. 113 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sarah Shigdar Breakdown of academic impact, for papers by Jun Qian Breakdown of academic impact, for papers by In-San Kim Breakdown of academic impact, for papers by Guanbin Song Breakdown of academic impact, for papers by Masamitsu Tanaka Breakdown of academic impact, for papers by Shinae Kizaka‐Kondoh Breakdown of academic impact, for papers by Wanhai Xu Breakdown of academic impact, for papers by Abhijit De Breakdown of academic impact, for papers by Maryam Moghaddam Matin Breakdown of academic impact, for papers by Haruhiko Kamada
Rankless by CCL
2026